Combined Oral Administration of L-Arginine and Tetrahydrobiopterin in a Rat Model of Pulmonary Arterial Hypertension

Pulmonary Circulation - United States
doi 10.1177/2045893216677519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Effects of Inorganic Nitrate in a Rat Model of Monocrotaline‐induced Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Effects of Oral Supplementation of L-Arginine in the Treatment of Pulmonary Hypertension Secondary to Pulmonary Embolism: A Case Report

Fukushima Journal of Medical Sciences
Medicine
2010English

Oral Tadalafil in Children With Pulmonary Arterial Hypertension

Drug Research
MedicineDrug Discovery
2015English

Plexiform-Like Lesions and Increased Tissue Factor Expression in a Rat Model of Severe Pulmonary Arterial Hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2007English

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

Scientific Reports
Multidisciplinary
2018English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Vascular Compromise and Hemodynamics in Pulmonary Arterial Hypertension: Model Predictions

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Successful Titration of Triple Oral Therapy in a Patient With Pulmonary Arterial Hypertension (PAH)

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

EXPRESS: Sugen-Morphine (SuMo) Model of Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy